Transparency

COA Vault

Lot-specific source reports, measured results, pending tests and release status.

What a published lot record means

Each record links a product and package to its lot, laboratory and source report. The six-area peptide testing programme is distinct from the tests completed for that lot. A release based on HPLC purity and content can have additional tests pending. Measured results, VERIPHASE acceptance criteria and release status are separate information; publication is not a claim that every test passed.

11 / 11 public lots shown

Compound / Lot	Measured result	Status	Report
Tesamorelin10mg Lot 26-0039VP-TESA-10 · current	HPLC purity 99% Measured peptide content 9.67 mg Reported Additional lot evidence Measured peptide content 9.67 mgHPLC; updated report 100019720 received 2026-10-30, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019720; report YDZERYQV; sample lot 26-0039
RetatrutideGLP-3 RT · LY3437943 · 24mg Lot 26-0035VP-RT-24 · current	HPLC purity 99% Measured peptide content 24.34 mg Reported Additional lot evidence Measured peptide content 24.34 mgHPLC; original report 100019723, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019723; report 6BSGA3W7; sample lot 26-0035 Sold as 24 mg (SKU VP-RT-24). The original laboratory sample was labelled 30 mg (COA reference VP-RT-30); this is the same lot 26-0035. The report measured 24.34 mg in the tested sample. The original COA and its photographs are unchanged. The product image shows the revised commercial label; VP-RT-30 is retained only as the COA reference.
RetatrutideGLP-3 RT · LY3437943 · 18mg Lot 26-0034VP-RT-18 · current	HPLC purity 99% Measured peptide content 18.06 mg Reported Additional lot evidence Measured peptide content 18.06 mgHPLC; original report 100019722, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019722; report EFU6Z1C9; sample lot 26-0034 Sold as 18 mg (SKU VP-RT-18). The original laboratory sample was labelled 20 mg (COA reference VP-RT-20); this is the same lot 26-0034. The report measured 18.06 mg in the tested sample. The original COA and its photographs are unchanged. The product image shows the revised commercial label; VP-RT-20 is retained only as the COA reference.
RetatrutideGLP-3 RT · LY3437943 · 10mg Lot 26-0033VP-RT-10 · current	HPLC purity 99% Measured peptide content 10.31 mg Reported Additional lot evidence Measured peptide content 10.31 mgHPLC; original report 100019721, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019721; report A90GOAOL; sample lot 26-0033
MOTS-c9mg Lot 26-0040VP-MOTSC-9 · current	HPLC purity 99% Measured peptide content 9.10 mg Reported Additional lot evidence Measured peptide content 9.10 mgHPLC; original report 100019715, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019715; report DM5PAPY0; sample lot 26-0040 Sold as 9 mg (SKU VP-MOTSC-9). The original laboratory sample was labelled 10 mg (COA reference VP-MOTSC-10); this is the same lot 26-0040. The report measured 9.10 mg in the tested sample. The original COA and its photographs are unchanged. The product image shows the revised commercial label; VP-MOTSC-10 is retained only as the COA reference.
Ipamorelin10mg Lot 26-0041VP-IPAM-10 · current	HPLC purity 99% Measured peptide content 10.64 mg Reported Additional lot evidence Measured peptide content 10.64 mgHPLC; original report 100019716, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019716; report 03OOFX3U; sample lot 26-0041
GHK-Cu100mg Lot 26-0036VP-GHKCU-100 · current	HPLC purity 99% Measured peptide content 103.12 mg Reported Additional lot evidence Measured peptide content 103.12 mgHPLC; original report 100019718, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019718; report VIC4JDRE; sample lot 26-0036
CJC-1295 No-DAC + Ipamorelin5+5mg Lot 26-0042VP-CJC-IPA-55 · current	HPLC purity CJC-1295 no DAC: 99%; Ipamorelin: 99% Measured peptide content: CJC-1295 No-DAC 4.50 mg Measured peptide content: Ipamorelin 5.25 mg Reported Additional lot evidence Measured peptide content: CJC-1295 No-DAC 4.50 mgHPLC; original report 100019714, pages 1-2 Measured peptide content: Ipamorelin 5.25 mgHPLC; original report 100019714, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019714; report UIWE9XON; sample lot 26-0042
BPC-157 + TB-500 (Tβ4 Frag)5+5mg Lot 26-0038VP-BPC-TB-55 · current	HPLC purity BPC-157: 99%; TB-4 Fragment: 99% Measured peptide content: BPC-157 4.72 mg Measured peptide content: Thymosin Beta 4 fragment 4.65 mg Reported Additional lot evidence Measured peptide content: BPC-157 4.72 mgHPLC; original report 100019719, pages 1-2 Measured peptide content: Thymosin Beta 4 fragment 4.65 mgHPLC; original report 100019719, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019719; report MT8NOT9P; sample lot 26-0038
BPC-1579mg Lot 26-0037VP-BPC-9 · current	HPLC purity 99% Measured peptide content 8.90 mg Reported Additional lot evidence Measured peptide content 8.90 mgHPLC; original report 100019717, pages 1-2	Released Additional tests pending View pending tests MS identity — Pending Endotoxin — Pending Elemental impurities — Pending Bioburden — Pending Sterility — Pending HPLC purity and content are reported for this lot. Additional tests remain pending; this is not a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019717; report UFTOUJ1F; sample lot 26-0037 Sold as 9 mg (SKU VP-BPC-9). The original laboratory sample was labelled 10 mg (COA reference VP-BPC-10); this is the same lot 26-0037. The report measured 8.90 mg in the tested sample. The original COA and its photographs are unchanged. The product image shows the revised commercial label; VP-BPC-10 is retained only as the COA reference.
Bacteriostatic Water10mL Lot 26-0043VP-BACW-10 · current	Solution quality BA assay 0.89% Reported	Released Additional tests pending View pending tests pH — Pending Sterility — Pending Endotoxin — Pending The benzyl alcohol assay is reported as 0.89% for this lot. pH, sterility and endotoxin tests remain pending. This limited release does not confirm sterility or a complete test panel.	Open COA · PDF ↗ Analiza Bialek sp. z o.o.Report date: 2026-10-28 Report details Source ref: Analiza order 100019677; report IYVM0UG1; sample lot 26-0043